Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
X-linked lymphoproliferative disease (XLP) is a rare congenital immunodeficiency that leads to an extreme, usually fatal increase in the number of lymphocytes upon infection with EBV. It is most commonly defined molecularly by loss of expression of SLAM-associated protein (SAP). Despite this, there is little understanding of how SAP deficiency causes lymphocytosis following EBV infection. Here we show that T cells from individuals with XLP are specifically resistant to apoptosis mediated by TCR restimulation, a process that normally constrains T cell expansion during immune responses. Expression of SAP and the SLAM family receptor NK, T, and B cell antigen (NTB-A) were required for TCR-induced upregulation of key pro-apoptotic molecules and subsequent apoptosis. Further, SAP/NTB-A signaling augmented the strength of the proximal TCR signal to achieve the threshold required for restimulation-induced cell death (RICD). Strikingly, TCR ligation in activated T cells triggered increased recruitment of SAP to NTB-A, dissociation of the phosphatase SHP-1, and colocalization of NTB-A with CD3 aggregates. In contrast, NTB-A and SHP-1 contributed to RICD resistance in XLP T cells. Our results reveal what we believe to be novel roles for NTB-A and SAP in regulating T cell homeostasis through apoptosis and provide mechanistic insight into the pathogenesis of lymphoproliferative disease in XLP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
Self-citationThe many roles of FAS receptor signaling in the immune system
Strasser, A., Jost, P. J., & Nagata, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.001 · Cited by 968 · cited 2×
“antigen stimulation and does not distinguish between the possible mechanisms of lymphocyte apoptosis described above (22).”
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Self-citationSayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943 · cited 3×
“XLP commonly results from deficiency of SLAM-associated protein (SAP), also designated XLP1, caused by mutations in the SH2D1A gene on chromosome Xq24-25 (11–13).”
Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754 · cited 1×
“XLP commonly results from deficiency of SLAM-associated protein (SAP), also designated XLP1, caused by mutations in the SH2D1A gene on chromosome Xq24-25 (11–13).”
SAP-controlled T–B cell interactions underlie germinal centre formation
Qi, H., Cannons, J. L., Klauschen, F., Schwartzberg, P. L., & Germain, R. N. (2008) · Nature · doi:10.1038/nature07345 · Cited by 637 · cited 1×
“org Volume 119 Number 10 October 2009 2987 (42).”
X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)
Purtilo, D., Yang, J. S., Cassel, C., Harper, R., Stephenson, S., Landing, B., & Vawter, G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92004-8 · Cited by 553 · cited 1×
“X-linked lymphoproliferative disease (XLP) is a rare congenital immunodeficiency originally described by David Purtilo and colleagues in 1975 (6).”
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
Self-citationX-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
Štefanová, I., Hemmer, B., Vergelli, M., Martin, R., Biddison, W. E., & Germain, R. N. (2003) · Nature Immunology · doi:10.1038/ni895 · Cited by 465 · cited 1×
“In the absence of SAP, TCR signaling effectively becomes weaker, resembling a partial agonist signal that involves negative feedback loops like those controlled by SHP-1 in response to weakly binding ligands (41).”
Cited by
T cell receptor (TCR) signaling in health and disease
Shah, K., Al-Haidari, A., Sun, J., & Kazi, J. U. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00823-w · Cited by 604
SLAM Family Receptors and SAP Adaptors in Immunity
Cannons, J. L., Tangye, S. G., & Schwartzberg, P. L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101302 · Cited by 497
Pediatric hemophagocytic lymphohistiocytosis
Canna, S. W., & Marsh, R. A. (2020) · Blood · doi:10.1182/blood.2019000936 · Cited by 496
Self-citationOliveira, J. B., Bleesing, J. J., Dianzani, U., Fleisher, T. A., Jaffe, E. S., Lenardo, M. J., Rieux-Laucat, F., Siegel, R. M., Su, H. C., Teachey, D. T., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280347 · Cited by 495
Self-citationSchmid, J. P., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F., Kanegane, H., Lopez-Granados, E., Mejstrikova, E., Pellier, I., et al. (2011) · Blood · doi:10.1182/blood-2010-07-298372 · Cited by 363
Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines
Filipovich, A., McClain, K., & Grom, A. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.11.014 · Cited by 294
Self-citationMarsh, R. A., Madden, L., Kitchen, B. J., Mody, R., McClimon, B., Jordan, M. B., Bleesing, J. J., Zhang, K., & Filipovich, A. H. (2010) · Blood · doi:10.1182/blood-2010-01-256099 · Cited by 264
Self-citationEpstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
Marsh, R. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01902 · Cited by 178
Self-citationHuman immunity against EBV—lessons from the clinic
Tangye, S. G., Palendira, U., & Edwards, E. S. J. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161846 · Cited by 174
“…deficiency remain unclear, particularly as SAP deficiency protects T cells from restimulation-induced cell death allowing prolonged proliferation (Snow et al., 2009; Palendira et al., 2012), with HLH characterized by dysregulated proliferation of cytotoxic lymphocytes (Filipovich et al., 2010;…”
BackgroundInfluentialFOXP3 protects conventional human T cells from premature restimulation-induced cell death
Voss, K., Lake, C., Luthers, C. R., Lott, N. M., Dorjbal, B., Arjunaraja, S., Bauman, B. M., Soltis, A. R., Sukumar, G., Dalgard, C. L., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0316-z · Cited by 21
Self-citation
Metadata
- Authors
- Snow, A. L., Marsh, R. A., Krummey, S. M., Roehrs, P., Young, L. R., Zhang, K., van Hoff, J., Dhar, D., Nichols, K. E., Filipovich, A. H., Su, H. C., Bleesing, J. J., & Lenardo, M. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-09-14
- Volume
- 119
- Issue
- 10
- Pages
- 2976-89
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2121798637
- Cited by
- 164
- References
- 37
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.